Alliance Pharmaceuticals

Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB
Telephone: +44 (0)1249 466 966
Fax: +44 (0)1249 466 977
WWW: http://www.alliancepharma.co.uk
Medical Information e-mail: medinfo@alliancepharma.co.uk

Summary of Product Characteristics last updated on the eMC: 02/02/2011
SPC Testosterone Enantate Ampoules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 02/02/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
Date of revision of text on the SPC:   10-Jan-2011
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Change of Marketing Authorisation Holder from Cambridge Laboratories to Alliance Pharmaceuticals Ltd
Updated on 30/09/2003 and displayed until 02/02/2011
Reasons for adding or updating:
  • Correction of spelling/typing errors
  • Change to section 5.2 - Pharmacokinetic Properties
Updated on 26/11/2001 and displayed until 30/09/2003
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 06/07/2001 and displayed until 26/11/2001
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
Updated on 06/09/1999 and displayed until 06/07/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   testosterone enantate